Impact of Selective Immunosuppressive Therapy on Subsequent Immune-Related Adverse Events After Immune Checkpoint Inhibitor-Induced Colitis Treatment : American Journal of Clinical Oncology

Secondary Logo

Journal Logo

Original Article

Impact of Selective Immunosuppressive Therapy on Subsequent Immune-Related Adverse Events After Immune Checkpoint Inhibitor-Induced Colitis Treatment

Pizuorno Machado, Antonio MD*; Shatila, Malek MD; Glitza Oliva, Isabella C. MD, PHD, MS; Altan, Mehmet MD§; Siddiqui, Bilal MD; Zhou, Yan MD, PHD; Varatharajalu, Krishnavathana MD; Zhang, Hao Chi MD; Thomas, Anusha MD; Wang, Yinghong MD, PHD

Author Information
American Journal of Clinical Oncology ():10.1097/COC.0000000000001016, May 23, 2023. | DOI: 10.1097/COC.0000000000001016

Abstract

Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

Full Text Access for Subscribers:

You can read the full text of this article if you:

Access through Ovid